Results 71 to 80 of about 9,221 (233)

Study the Expression of Dickkopf-related Protein 3 Immunoreactivity in Serous Epithelial Ovarian Tumors

Medical Journal of Babylon
Background: Dickkopf-related protein 3 (DKK3) is regarded as a tumor suppressor in cancer tissue. DKK3 gene effect has an important role in the prognosis of ovarian cancer with the possibility to discover new line treatment in ovarian cancer.
Ammar Eesa Mahdi, Ali Zaki Naji
doaj   +1 more source

Is this disseminated ovarian cancer or not? [PDF]

, 2018
This is now the second half of the 1980s, I’ve been a consultant surgical pathologist at the Royal Hampshire County Hospital in Winchester since 1980, and I get a phone call from a friend in Malta who says his wife has just been diagnosed with ovarian ...
Cilia Vincenti, Albert
core  

Deep convolutional neural networks for multiple histologic types of ovarian tumors classification in ultrasound images

Frontiers in Oncology, 2023
ObjectiveThis study aimed to evaluate and validate the performance of deep convolutional neural networks when discriminating different histologic types of ovarian tumor in ultrasound (US) images.Material and methodsOur retrospective study took 1142 US ...
Meijing Wu, Guangxia Cui, Shuchang Lv, Lijiang Chen, Zongmei Tian, Min Yang, Wenpei Bai   +6 more
doaj   +1 more source

Integrating Thyroid Autoantibodies With CA125 Enhances Diagnostic Precision for Ovarian Endometriosis: A Retrospective Study of 885 Patients

Journal of Obstetrics and Gynaecology Research, Volume 51, Issue 10, October 2025.
ABSTRACT Aim This study aimed to compare clinical characteristics and evaluate diagnostic biomarkers in ovarian endometriosis, with a focus on thyroid autoimmunity associations. Methods A retrospective analysis of 885 patients (441 ovarian endometriosis cases; 444 benign ovarian tumor controls) was conducted.
Yufeng Wang, Zhiruo Qiu, Yuan Yao, Jie Tan, Xuan Che   +4 more
wiley   +1 more source

The Expression and Clinical Significance of C1orf106 in Low‐Grade Serous Ovarian Cancer

Journal of Obstetrics and Gynaecology Research, Volume 51, Issue 10, October 2025.
ABSTRACT Aim Low‐grade serous ovarian cancer (LGSOC) is a rare subtype of ovarian cancer with distinct biological behavior. This study aimed to identify new biomarkers with potential diagnostic and prognostic value for LGSOC. Methods Gene‐expression data were downloaded from the Gene Expression Omnibus (GEO).
Feifei Song, Xiaojing Chen, Tao Zhang, Xuedong Tang, Xiaodong Cheng   +4 more
wiley   +1 more source

Borderline ovarian tumors [PDF]

, 2006
Borderline ovarian tumors are classified between benign cystadenoma and malignant cystadenocarcinoma. They are characterized as malignant tumors by histopathological features, which make them different from the benign ones.
Ivković-Kapicl Tatjana, Mastilović Katarina, Ninčić Dejan, Rajović Jelka, Živaljević Milica   +4 more
core   +1 more source

Cancer of the ovary, fallopian tube, and peritoneum: 2025 update

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 6-35, September 2025.
Abstract In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high‐grade serous carcinomas (HGSCs).
Malte Renz, Michael Friedlander, Jonathan S. Berek   +2 more
wiley   +1 more source

Mucinous cystic neoplasms of the pancreas and liver share a similar DNA methylation profile with mucinous ovarian tumors

The Journal of Pathology, Volume 267, Issue 1, Page 10-24, September 2025.
Abstract The origin of mucinous cystic neoplasms (MCNs) remains a major challenge in hepato‐pancreato‐biliary pathology. These cystic tumors are defined by their mucinous epithelium and ovarian‐like stroma, with an estimated 10% risk of progression to invasive carcinoma. The origin of the ovarian‐like stroma remains a subject of debate.
Zoe Leoni, Teodor G Calina, Tobias Janik, Elena Grafenhorst, Eliane T Taube, Christopher CM Neumann, BaoQing Chen, Elena I Braicu, Jalid Sehouli, Thomas Malinka, Wenzel Schöning, Johann Pratschke, George A Calin, David S Klimstra, Jamal K Benhamida, Irene Esposito, Markus Möbs, David Horst, Simon Schallenberg, David Capper, Mihnea P Dragomir   +20 more
wiley   +1 more source

An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Clinical Proteomics, 2017
Background Epithelial ovarian carcinomas encompass a heterogeneous group of diseases with a poor 5-year survival rate. Serous carcinoma is the most common type. Most FDA-approved serum tumor markers are glycoproteins.
Qing Kay Li, Punit Shah, Yuan Tian, Yingwei Hu, Richard B. S. Roden, Hui Zhang, Daniel W. Chan   +6 more
doaj   +1 more source

Plasmonic Mesoporous Gold‐Based SERS Biosensor for Ovarian Cancer‐Derived Extracellular Vesicles

Small, Volume 21, Issue 34, August 28, 2025.
The nanoengineered mesoporous gold (mAu)‐based SERS platform enables rapid, sensitive detection of PLAP‐positive extracellular vesicles (EVs) in ovarian cancer (OC), with detection limits as low as 100 EVs mL−1. Achieving over 80% sensitivity and 98% specificity in clinical samples, this cost‐effective, non‐invasive tool shows promise for early cancer ...
Javeria Bashir, Mostafa Kamal Masud, Asep Sugih Nugraha, Chia‐Hung Liu, Arya Vasanth, Aditya Ashok, S M Azad Hossain, Emtiaz Ahmed, Tanja Pejovic, Terry Morgan, John Hooper, Andrew Lai, Dominic Guanzon, Yusuf Valentino Kaneti, Md Shahriar A. Hossain, Carlos Salomon, Yusuke Yamauchi   +16 more
wiley   +1 more source